Charles Dadswell
General Counsel bei ILLUMINA, INC.
Vermögen: 3 Mio $ am 31.03.2024
Profil
Derzeit ist Charles E. Dadswell Secretary, Senior VP & Compliance Officer bei Illumina, Inc. In seiner früheren Karriere war Charles E. Dadswell General Counsel bei BioDelivery Sciences International, Inc. und Vice President-US Intellectual Property bei GlaxoSmithKline, Inc. sowie VP & General Counsel-North & Latin America bei bioMerieux, Inc. Charles E. Dadswell erhielt einen Bachelor-Abschluss von der Ferris State University (Michigan), einen Graduierten-Abschluss von der Thomas M. Cooley Law School und einen Graduierten-Abschluss von der George Washington University Law School.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ILLUMINA, INC.
0,01% | 05.03.2024 | 22 298 ( 0,01% ) | 3 Mio $ | 31.03.2024 |
Aktive Positionen von Charles Dadswell
| Unternehmen | Position | Beginn |
|---|---|---|
| ILLUMINA, INC. | General Counsel | 22.04.2013 |
Ehemalige bekannte Positionen von Charles Dadswell
| Unternehmen | Position | Ende |
|---|---|---|
bioMérieux, Inc.
 bioMérieux, Inc. Medical SpecialtiesHealth Technology bioMérieux, Inc. develops in-vitro diagnostics solutions. It offers microbiological testing solutions for medical and industrial applications. The company was founded on December 31, 1986 and is headquartered in Durham, NC. | General Counsel | 01.04.2013 |
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | General Counsel | 01.01.2010 |
| Glaxo Wellcome, Inc. | Corporate Officer/Principal | - |
GlaxoSmithKline, Inc.
 GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Corporate Officer/Principal | - |
Ausbildung von Charles Dadswell
| Ferris State University (Michigan) | Undergraduate Degree |
| The Thomas M. Cooley Law School | Graduate Degree |
| George Washington University Law School | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ILLUMINA, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
BioDelivery Sciences International, Inc.
 BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology BioDelivery Sciences International, Inc. operates as a pharmaceutical company engaged in the development and commercialization of new applications of approved therapeutics to address important unmet medical needs. Its products include Symproic and Belbuca. The company was founded on January 6, 1997 and is headquartered in Raleigh, NC. | Health Technology |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Health Technology |
bioMérieux, Inc.
bioMérieux, Inc. Medical SpecialtiesHealth Technology bioMérieux, Inc. develops in-vitro diagnostics solutions. It offers microbiological testing solutions for medical and industrial applications. The company was founded on December 31, 1986 and is headquartered in Durham, NC. | Health Technology |
| Glaxo Wellcome, Inc. | Health Technology |
